KRAS Mutation in Small Cell Lung Carcinoma and Extrapulmonary Small Cell Cancer. - Wikidata - awgldk - TriplyDB

KRAS Mutation in Small Cell Lung Carcinoma and Extrapulmonary Small Cell Cancer.

KRAS Mutation in Small Cell Lung Carcinoma and Extrapulmonary Small Cell Cancer.

http://www.wikidata.org/entity/Q37211434

about

Progression inference for somatic mutations in cancer.

P2860

Q38793244-089C15CA-4031-4C32-A152-1F65164289E5

P2860

KRAS Mutation in Small Cell Lung Carcinoma and Extrapulmonary Small Cell Cancer.

http://www.wikidata.org/entity/Q37211434

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on July 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

KRAS Mutation in Small Cell Lung Carcinoma and Extrapulmonary Small Cell Cancer.

@en

KRAS Mutation in Small Cell Lung Carcinoma and Extrapulmonary Small Cell Cancer.

@nl

type

label

KRAS Mutation in Small Cell Lung Carcinoma and Extrapulmonary Small Cell Cancer.

@en

KRAS Mutation in Small Cell Lung Carcinoma and Extrapulmonary Small Cell Cancer.

@nl

prefLabel

KRAS Mutation in Small Cell Lung Carcinoma and Extrapulmonary Small Cell Cancer.

@en

KRAS Mutation in Small Cell Lung Carcinoma and Extrapulmonary Small Cell Cancer.

@nl

P1433

Q37211434-C4B047CB-3468-4C68-A03E-E5CE963BADDA

P1476

Q37211434-BB78EE59-0C99-40A3-AA1F-CC5458545041

P2093

Q37211434-2702E7D3-9757-45DF-B00A-E8729EA63D5E

Q37211434-43F24848-A189-44CC-AE16-6CE1DB3D5301

Q37211434-4BA2055D-7314-4AC1-9FC0-0F0D169A485B

Q37211434-556CD8F0-F8AF-48D1-8A4E-AB0DFCCD0CC4

Q37211434-8D274455-D543-449D-ADCD-EA6242353DBD

Q37211434-D21C6881-A1D7-489E-987E-8D6956FD5E4E

Q37211434-D321C862-9426-46F4-B3D6-D01CBCD57CB4

Q37211434-E441394E-F13E-47A9-A690-9547EFF01193

Q37211434-F9430081-574A-4920-8B52-BAF232633CFE

Q37211434-FFC26E4E-49D4-4D93-830D-1CB20EEB5CA5

P2860

Q37211434-0285C32D-2729-418E-9655-669A13A4DF82

Q37211434-08AE8021-E00D-4A87-AF12-754997F2AAB5

Q37211434-11FA9195-91C6-4A93-8C2D-A41D4BE561F3

Q37211434-21765AE8-EB58-476D-8985-99AF58C1354F

Q37211434-28A3F2FD-EF56-422C-BBB0-A9E649024434

Q37211434-308ED01B-6D72-40E6-B12B-685BCEB3795D

Q37211434-46B34649-62C2-4650-A60E-A2144568CDA5

Q37211434-564D10AF-7425-4E0D-A192-528A9650143A

Q37211434-57CD61A7-531C-42FF-8FDE-1385FB45F1B5

Q37211434-5C38692F-8A40-4C78-8F81-28AC30948411

P304

Q37211434-9C60A1B0-E560-49E6-81E3-792923E50766

P31

Q37211434-3A026E71-12CB-4E52-B615-DAE099960C34

P356

Q37211434-5B462B70-A9A8-4D1C-BEB0-7A378938ACFA

P433

Q37211434-137403C1-9DB8-473F-807E-EE77E1721408

P478

Q37211434-1B9C35BE-DBCE-4D27-9D7B-D463220CDAA9

P577

Q37211434-27831957-D75D-429F-BCE8-7FC7F255032F

P698

Q37211434-3EDFD745-CC12-4EC3-94C5-BC85641E4726

P932

Q37211434-4C57BF88-6D47-48F5-B660-FBC4D391E0AA

P356

BALKANMEDJ.2016.150610

P1433

Balkan medical journal

P1476

KRAS Mutation in Small Cell Lung Carcinoma and Extrapulmonary Small Cell Cancer.

@en

P2093

Bora Demirkan

http://www.w3.org/2001/XMLSchema#string

Bülent Erdoğan

http://www.w3.org/2001/XMLSchema#string

Ebru Taştekin

http://www.w3.org/2001/XMLSchema#string

Esma Türkmen

http://www.w3.org/2001/XMLSchema#string

Hakan Gürkan

http://www.w3.org/2001/XMLSchema#string

Hilmi Kodaz

http://www.w3.org/2001/XMLSchema#string

Hilmi Tozkır

http://www.w3.org/2001/XMLSchema#string

Sernaz Uzunoğlu

http://www.w3.org/2001/XMLSchema#string

İlhan Hacıbekiroğlu

http://www.w3.org/2001/XMLSchema#string

İrfan Çiçin

http://www.w3.org/2001/XMLSchema#string

P2860

The COSMIC (Catalogue of Somatic Mutations in Cancer) database and website

Pooled analysis of the prognostic and predictive effects of KRAS mutation status and KRAS mutation subtype in early-stage resected non-small-cell lung cancer in four trials of adjuvant chemotherapy.

Frequency and distinctive spectrum of KRAS mutations in never smokers with lung adenocarcinoma.

Anaplastic lymphoma kinase inhibition in non-small-cell lung cancer.

Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a multicentre, open-label, randomised phase 3 trial.

Cancer statistics, 2015

The epidemiology and survival of extrapulmonary small cell carcinoma in South East England, 1970-2004

PIK3CA mutations and copy number gains in human lung cancers.

Association between specific KRAS mutations and the clinicopathological characteristics of colorectal tumors.

The transcriptional landscape and mutational profile of lung adenocarcinoma.

P304

407-410

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.5152/BALKANMEDJ.2016.150610

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

33

http://www.w3.org/2001/XMLSchema#string

P577

2016-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27606136

http://www.w3.org/2001/XMLSchema#string

P932

5001818

http://www.w3.org/2001/XMLSchema#string